Claude Nicaise
Director · Gain Therapeutics, Inc.
Individual
- 2025
- Jul 17, 2026
- 4
Other insiders active in the same sector
No other insider has filed at Claude Nicaise's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Mario Schlosser - $62.90M in OSCR purchases and sales in the last 12 months
- BROADWOOD PARTNERS, L.P. - $62.75M in STAA purchases and sales in the last 12 months
- Jonathan M. Rothberg - $62.19M in BFLY purchases and sales in the last 12 months
- Jeffrey M. Leiden - $60.94M in VRTX purchases and sales in the last 12 months
- Dinesh V. Ph D. Patel - $60.58M in PTGX purchases and sales in the last 12 months
- David Cordani - $60.11M in CI purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Claude Nicaise?
Claude Nicaise is a corporate insider, tracked as Director of Gain Therapeutics, Inc. (GANX). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Claude Nicaise submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
